Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Jazz brings in $80mm with debt financing

Executive Summary

Jazz Pharmaceuticals (neurological therapeutics) has raised $80mm through the private placement of senior debt to lead investor Lehman Brothers. General Electric Pension Trust, Deep Cover Mezzanine, and Oak Hill Advisors and Investment Management also participated. Jazz originally planned to offer $75mm worth of notes.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register